Hemorise Injection 100 mg/2 ml is an intravenous iron preparation containing Ferric Carboxymaltose, intended for the treatment of iron deficiency and iron deficiency anemia in patients who cannot tolerate or respond adequately to oral iron therapy. This low-dose formulation is ideal for gradual correction of iron deficiency, especially in pediatric, geriatric, or sensitive patients requiring controlled dosing.
Iron deficiency is a common nutritional and medical concern that can lead to fatigue, impaired cognitive function, reduced immunity, and compromised physical performance. Hemorise Injection 100 mg/2 ml provides a highly bioavailable source of iron that is essential for hemoglobin synthesis, red blood cell production, and oxygen transport throughout the body.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Each 2 ml vial of Hemorise Injection contains:
Ferric Carboxymaltose 100 mg
Ferric Carboxymaltose is a stable, complexed form of iron that ensures controlled release of elemental iron, reducing the risk of toxicity and allowing safe administration even in small doses.
Ferric Carboxymaltose acts as a direct source of iron for the body:
After intravenous administration, iron is taken up by the reticuloendothelial system.
Iron is gradually released to bind transferrin, which transports it to the bone marrow.
In the bone marrow, iron is utilized for hemoglobin synthesis and incorporation into new red blood cells.
Controlled release minimizes the presence of free iron in circulation, reducing oxidative stress and adverse reactions.
This mechanism supports effective replenishment of iron stores and helps restore normal hemoglobin levels safely.
Hemorise Injection 100 mg/2 ml is indicated for:
Iron deficiency anemia in patients who cannot tolerate oral iron therapy
Gradual correction of mild to moderate iron deficiency
Pediatric patients and elderly patients requiring low-dose intravenous iron
Patients with chronic conditions where oral iron supplementation is inadequate
Gradual and controlled replenishment of iron stores
Safe for patients with sensitive gastrointestinal systems who cannot tolerate oral iron
Supports recovery from anemia and improves energy, immunity, and cognitive function
Reduces the need for frequent hospital visits compared to multiple oral doses
Well-tolerated with minimal systemic side effects
Hemorise Injection 100 mg/2 ml should be administered intravenously under medical supervision. The recommended dose is 100 mg, diluted in 50–100 ml of 0.9% sodium chloride, infused over at least 15 minutes. Repeat dosing may be required based on the patient’s iron deficit, hemoglobin levels, and response to therapy.
Patients should be monitored during and after infusion for signs of hypersensitivity or adverse reactions. Emergency measures should be available in case of rare anaphylactic reactions.
Administer only under the supervision of a qualified healthcare professional.
Monitor for hypersensitivity reactions and hypotension during and after infusion.
Use caution in patients with a history of hypersensitivity to intravenous iron formulations.
Not suitable for patients with iron overload or hemochromatosis.
Ensure correct calculation of total iron requirements to avoid overdose.
Common side effects may include:
Mild headache, dizziness, or nausea
Temporary injection site reactions such as pain, redness, or swelling
Rarely, hypersensitivity or anaphylactic reactions
Most adverse effects are mild and transient when administered according to recommended protocols
Store below 30°C in a cool, dry place, protected from light. Do not freeze. Keep out of reach of children.
Hemorise Injection 100 mg/2 ml is a safe and effective option for gradual iron supplementation, supporting hemoglobin restoration, anemia management, and overall patient health under proper medical supervision.
Login Or Registerto submit your questions to seller
No none asked to seller yet